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Abstract The emerging crisis in antibiotic resistance and
concern that we now sit on the precipice of a post-antibiotic
era have given rise to advocacy at the highest levels for
widespread adoption of programmes that promote judicious
use of antibiotics. These antibiotic stewardship pro-
grammes, which seek to optimize antibiotic choice when
clinically indicated and discourage antibiotic use when
clinically unnecessary, are being implemented in an
increasing number of acute care facilities, but their adop-
tion has been slower in nursing homes. The antibiotic
prescribing process in nursing homes is fundamentally
different from that observed in hospital and clinic settings,
with formidable challenges to implementation of effective
antibiotic stewardship. Nevertheless, an emerging body of
research points towards ways to improve antibiotic pre-
scribing practices in nursing homes. This review summa-
rizes the findings of this research and presents ways in
which antibiotic stewardship can be implemented and
optimized in the nursing home setting.
Key Points
The antibiotic prescribing process in nursing homes
is complex and differs from the prescribing process
in hospital and clinic settings.
Improvements in the quality of antibiotic prescribing
in nursing homes have been achieved through a
variety of antibiotic stewardship interventions.
Implementing and sustaining antibiotic stewardship
in nursing homes requires an organizational
commitment and a strategy based on goal setting,
process and outcome measurement, and continuous
quality improvement.
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It is not difficult to make microbes resistant to peni-
cillin … The time may come when penicillin can be
bought by anyone in the shops. Then there is the
danger that the ignorant man may easily under dose
himself and by exposing his microbes to non-lethal
quantities of the drug make them resistant.
-Alexander Fleming’s Nobel Prize
Acceptance Lecture, 1945
1 Introduction
The discovery of penicillin in 1928, followed by its com-
mercialization in the 1940s, ushered in the antibiotic era of
medicine [1]. During that time, unparalleled advances in
health care were achieved, largely through a new-found
capacity to eradicate infections associated with disease
states that had previously rendered their treatment
unthinkable. Nevertheless, excessive use of antibiotics in
the ensuing decades, coupled with underinvestment in
discovery and development of new agents, has culminated
in a crisis of antibiotic resistance [2], which, if left
unchecked, will have catastrophic consequences for
patients and the economy [3]. In response, specialty soci-
eties [4] and governmental authorities [5, 6] have advo-
cated for a substantial increase in antibiotic stewardship
activity across the health care continuum. To date, efforts
to implement these antibiotic stewardship programmes
(ASPs)—which are defined as coordinated efforts to opti-
mize patient outcomes and reduce the emergence and
spread of antibiotic resistance through promotion of
appropriate antibiotic use—have focused on the hospital
setting. However, as is described below, the need for
similar efforts in nursing homes (including the care of
short-stay residents with skilled nursing and rehabilitation
needs, as well as long-stay residents) may be even greater.
Fortunately, a considerable number of studies focused on
improving antibiotic prescribing in nursing homes have
been published in recent years. Consequently, the primary
aims of this paper are to review the current literature on
antibiotic stewardship in nursing homes and provide rec-
ommendations that facilities can implement in order to
improve existing antibiotic prescribing patterns.
2 The Need for Antibiotic Stewardship in Nursing
Homes
While the numbers vary by country, approximately 2–5 %
of the developed world’s older population resides in some
type of long-term care facility [7, 8]. For example, nearly
1.4 million persons reside in the 15,700 nursing homes in
the USA [9]. Similar proportions of the populations in
Canada [10] and the UK [11] reside in this type of facility.
Residents in these facilities are predominantly frail and
prone to developing infections. In fact, infections are the
most common cause of transfers to acute care and a major
source of nursing home resident morbidity and mortality
[12, 13]. Against this backdrop, it is not surprising that
antibiotics are among the most commonly prescribed
medications in nursing homes [14]. On average, one in ten
nursing home residents is receiving antibiotics on any
given day [15–17]. For the resident who remains in a
nursing home for at least 6 months, this translates into a
40–70 % likelihood of exposure to at least one course of
antibiotics [14, 18].
While antibiotics are undoubtedly beneficial in many
situations, they are not uniformly benign or helpful.
Antibiotics pose a risk of adverse side effects similar to that
seen with antipsychotic medications [19] and account for
nearly 20 % of the adverse drug events observed in nursing
homes [20]. A resident’s risk of developing Clostridium
difficile infection (CDI), an increasingly common problem
encountered in nursing homes [21, 22], is amplified
eightfold following treatment of a suspected urinary tract
infection (UTI) [23]. Antibiotics also substantially increase
a resident’s risk of acquiring antibiotic-resistant bacteria
[24], which may result in subsequent infections that are
more expensive to treat [25] and are more likely to produce
adverse health outcomes [26–28]. Residents who become
colonized with antibiotic-resistant bacteria following
exposure to antibiotics may also spread these organisms to
other residents in the nursing home [29–32] and to indi-
viduals in other health care settings during care transitions
[33]. It is increasingly clear that a substantial number of
these resident harms could be avoided through improve-
ments in antibiotic prescribing practices in nursing homes.
Prospective studies have shown that nearly half of the
antibiotic courses prescribed in nursing homes are unnec-
essary [18, 23, 34–37]. Even when clinically indicated, the
antibiotic prescribed very often is excessively broad spec-
trum or is continued for a duration well beyond what is
required to eradicate the infection. Fluoroquinolones are
the most commonly prescribed class of antibiotics in US
and Canadian nursing homes, accounting for 38 and 23 %
of total antibiotic use, respectively [14, 17]. However, most
of the infections encountered in nursing homes can be
treated with alternative agents that pose lesser risks of side
effects and CDI [23, 35]. Despite a number of studies
demonstrating the safety and benefits of short-course
antibiotic therapy [38–40], more than 60 % of the residents
treated for nursing home infections receive antibiotics for
more than a week and nearly a third are treated for more
than 10 days [17].
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3 The Antibiotic Prescribing Process
Progress towards improving antibiotic prescribing practices
in nursing homes requires an understanding of the decision-
making involved. Antibiotic prescribing is best viewed as a
process rather than a discrete event (Fig. 1) [41]. Con-
ceptually, this process begins with a decision to initiate an
antibiotic, as well as a related decision about which
antibiotic(s) to prescribe. The initial decision to prescribe is
influenced by a number of factors (Fig. 2) [42–46],
although the relative influences of these factors vary not
only from case to case but also depending on the country.
For example, family preferences exert a considerable
influence over prescriber decision-making in US, Canadian
and Australian nursing homes [42, 43, 45, 47] but appear to
minimally impact prescribing decisions in Dutch nursing
homes [44].
In many nursing homes, the initial decision to prescribe
an antibiotic is made off-site by telephone and, therefore, is
heavily influenced by nursing home staff and inter-pro-
fessional communication [42, 43, 47]. Decisions are often
based on limited laboratory and clinical information, so
clinicians frequently prescribe broad-spectrum agents to
enhance coverage for a range of potential pathogens [45,
46]. Ideally, these same clinicians should then reassess the
patient several days later to decide if the empirical
antibiotic regimen can be de-escalated (Fig. 1). Consistent
application of post-prescribing review and de-escalation,
which is sometimes referred to as an ‘antibiotic timeout’
[48], allows the clinician to maximize the benefits of
antibiotics while minimizing their adverse effects [49].
This antibiotic timeout should involve review of accumu-
lated laboratory and imaging studies, as well as a re-eval-
uation of the patient’s status since initiating the antibiotic.
If the data suggest a non-infectious cause for the patient’s
illness, the antibiotic should be stopped. Conversely, if
these data point towards infection, then clinicians should
use the available culture results and observed changes in
the patient’s clinical status to select a definitive antibiotic
regimen that possesses the narrowest possible spectrum and
is given for the shortest possible duration.
4 Barriers to Improving Antibiotic Use in Nursing
Homes
The underlying frailty of most nursing home residents
engenders a high level of risk aversion among providers
who deliver care in the nursing home setting [46].
Immunosenescence and multimorbidity, both of which
increase a resident’s risk of infection, are the norm in
nursing homes [50, 51]. Reduced skin integrity and expo-
sure to invasive medical devices, such as indwelling uri-
nary catheters and feeding tubes, further compromise
intrinsic host immunity [52–54]. Even when infection is
identified and treated promptly, a resident’s risk of expe-
riencing adverse outcomes, such as hospitalization and
death, remains high.
Diagnosis of infection in aging populations remains a
challenge. Among older adults, temperature elevation (or
decline/depression) in response to infection is often blun-
ted. Cognitive impairment, which afflicts[50 % of nursing
home residents, makes it difficult for residents to vocalize
and/or localize their symptoms [55–59]. While nursing
homes have the capacity to perform common laboratory
tests, most rely upon off-site facilities for this service.
Consequently, even basic laboratory test results tend to be
reported a day or more after they are ordered, and culture
results take even longer. Moreover, while most nursing
homes have access to mobile radiographic services, the
image quality may be suboptimal [60].
The unique structure of resident evaluation and treat-
ment in nursing homes may represent the most important
barrier to improving antibiotic stewardship. While an
increasing number of providers in the USA and some other
countries practice primarily in the nursing home setting
[61, 62], the majority of care in nursing homes is delivered
by providers who, on average, physically spend less than
2 h per week in a nursing home [63, 64]. Consequently,
most antibiotic decisions are made by off-site providers
during brief telephone interactions with facility nursing
staff [65, 66]. This process relies heavily on certified
nursing assistants (CNAs) and licensed nursing staff.
A CNA is frequently the first individual to recognize a
Fig. 1 Components of the
antibiotic prescribing decision-
making process
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resident’s change in condition and can play a critical role in
assisting nursing staff in evaluation of the resident. How-
ever, resources devoted to the training of these individuals
is often minimal, and retention of experienced individuals
continues to be a challenge for many nursing homes [67,
68]. Accordingly, a registered nurse (RN) or licensed
practical nurse (LPN) must not only complete the initial
assessment and examination of a resident with a change in
condition but also communicate those findings to the pro-
vider on call. The nurses’ workload and familiarity with the
residents influence this process. Unfortunately, nurse-to-
resident ratios [69] and consistent assignments remain
suboptimal in many nursing homes [70]. Moreover, a high
reliance on agency staff [69], as well as high levels of staff
turnover [71], further compound the problem. It is, there-
fore, not surprising that providers often express frustration
over the quality of information received during their tele-
phone interactions with nursing home staff [72–74]. The
clinical uncertainty engendered by these assessment and
communication processes may, in part, lower the threshold
at which providers decide to prescribe an antibiotic [75,
76].
5 Existing Studies of Antibiotic Stewardship
in Nursing Homes
A loose definition of antibiotic stewardship encompassing
interventions to alter antibiotic prescribing patterns in
nursing homes, including decisions to initiate antibiotic
therapy, as well as the choice and duration of therapy, was
employed in the development of this review. A formal
systematic review process was not employed in the iden-
tification and quality assessment of the studies considered
in this review. However, the lead author (CJC) did conduct
a search of PubMed articles available as of April 2015,
reviewed citation lists from the retrieved review articles
[77–79] and further reviewed abstracts and presentations at
pertinent international scientific meetings (e.g. IDWeek) in
order to identify potential studies for review. Co-authors
contributed to the identification of additional articles not
identified by this initial retrieval process and also partici-
pated in the interpretation of individual study findings,
which were then synthesized through group consensus.
This process led to the identification of 14 studies focused
on altering antibiotic prescribing practices in nursing
homes (Table 1). Most of the interventions described in
these studies focused on empirical prescribing decision-
making through interventions to either reduce initiation of
unnecessary antibiotics (Q1 in Fig. 1) [80–87] or enhance
adherence to antibiotic prescribing guidelines (Q2 in
Fig. 1) [81, 83, 88–91]. The impacts of these interventions
on measured outcomes varied considerably across studies.
Nevertheless, review of the studies in aggregate points to
several promising strategies.
5.1 UTI-Focused Interventions
The most common indication for initiation of antibiotics in
nursing homes is UTI [14, 36, 92, 93]. Nevertheless, most
residents treated for UTI do not manifest symptoms that are
localized to the urinary tract [56]. Rather, studies suggest
that a substantial number of these events represent unnec-
essary treatment of asymptomatic bacteriuria [58, 94].
Fig. 2 Conceptual framework
of the factors that influence the
decision to initiate antibiotic
therapy in nursing homes
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Vague symptoms that have no clear relationship to the
urinary tract, such as malaise or falls, are often cited as a
reason to test resident urine samples [56]. Unfortunately,
urine diagnostic tests—including the rapid urine reagent
strip (dipstick), urinalysis and urine culture—fail to dis-
criminate between UTI and asymptomatic bacteriuria [95–
97]. Nonetheless, there is compelling evidence that positive
urine test results play an inordinate role in the decision to
initiate an antibiotic [94]. For example, 60–90 % of the
antibiotics prescribed for UTI in nursing homes are initi-
ated only after urine cultures results are available [56, 98].
Moreover, withholding urine culture results, unless
specifically requested by the provider, substantially reduces
the frequency of antibiotic starts in hospitals without
adversely affecting patient outcomes [99].
On the basis of these observations, it is reasonable to
hypothesize that antibiotic prescribing for UTI can be
reduced through interventions that target over-testing of
resident urine samples. The first large-scale study to test
this hypothesis employed criterion-based pathways to limit
urinary testing and antibiotic prescribing to residents with
fever and/or localizing urinary symptoms [80]. This study,
performed in 24 nursing homes in the USA and Canada,
demonstrated a reduction in antibiotic prescribing for UTI
(1.17 versus 1.59 antibiotic starts per 1000 resident-days),
but the effects waned over time, and there was a non-
significant impact on orders for urine cultures (2.03 versus
2.48 cultures per 1000 resident-days), suggesting issues
with intervention sustainability and fidelity [100]. Never-
theless, a subsequent study in a single Veterans Affairs
(VA) nursing home demonstrated an impressive reduction
in urine cultures (1.5 versus 3.7 cultures per 1000 resident-
days), treatment of asymptomatic bacteriuria (0.6 versus
1.7 courses per 1000 resident-days) and overall days of
antibiotic therapy (117 versus 168 days per 1000 resident-
days) following implementation of the same intervention
[82]. Similarly, treatment of asymptomatic bacteriuria was
reduced from 52 to 10 % (P = 0.001) following imple-
mentation of a cognitive intervention [101] focused on
limiting urine cultures in residents with guideline discor-
dant symptoms (e.g. foul-smelling urine) [87]. Finally,
significant reductions in urine cultures [incidence rate ratio
(IRR) 0.73; 95 % confidence interval (CI) 0.66 to 0.79]
and antibiotic therapy for UTI (IRR 0.67; 95 % CI
0.59–0.76) were achieved following implementation of a
quality improvement collaborative focused on improving
urine testing in 17 Massachusetts nursing homes [86].
5.2 Standardized Assessment and Communication
Interventions
Despite the availability of guidelines [102], there is evi-
dence that assessments of residents with possible infection
are suboptimal in many nursing homes [18, 34, 65]. Even
when the assessment is thorough, the quality of the com-
munication between facility nursing staff and providers,
which has been previously linked to use of antipsychotics
[103] and avoidable hospitalizations [73, 104], may be
suboptimal. While the linkage between communication and
antibiotic prescribing is less clear [42], interventions
structured around standardizing resident assessments and
interdisciplinary communication have led to reductions in
antibiotic use in nursing homes [84, 85]. A medical pro-
vider and nurse-based intervention—which included
training on antibiotic stewardship, a simple form that
facilitated standardization of communication with provi-
ders and an informational brochure for families and resi-
dents—led to lower overall antibiotic prescribing in
comparison with control facilities (IRR 0.86; 95 % CI
0.79–0.95) [85]. Similarly, antibiotic prescribing in Texas
nursing homes was 33 % lower in nursing homes that
implemented a standardized communication and UTI
decision-support form with high fidelity in comparison
with control nursing homes and facilities that implemented
the form with low fidelity [84].
5.3 Educational Interventions
Education can be an effective behavioural intervention
in situations where knowledge deficiencies drive observed
practice patterns [105]. The available studies suggest that
educational interventions have a modest impact on antibi-
otic use in nursing homes. The number of antibiotic starts
dropped by 26 % and days of antibiotic therapy were
reduced by 30 % following implementation of a case-based
educational intervention focused on treatment of com-
monly encountered infections in a Chicago long-term care
facility [81]. The impact of educational interventions when
delivered across multiple facility settings has been less
impressive. A cluster-randomized study of an educational
intervention to improve adherence to a prescribing guide-
line in Canadian nursing homes demonstrated improve-
ments in provider guideline adherence rates, but this
difference did not remain significant during long-term
follow-up [89]. Similarly, a cluster-randomized study of an
educational intervention to reduce fluoroquinolone uti-
lization in Swedish nursing homes did not demonstrate a
significant impact on this particular prescribing pattern,
although the proportion of infections treated with antibi-
otics was lower in intervention nursing homes compared
with control facilities (difference-in-differences of pro-
portions -0.124; 95 % CI -0.228 to -0.019) [83]. Inter-
estingly, the effectiveness of educational interventions may
rely on simultaneous delivery of content to facility nursing
staff and prescribing providers. A cluster-randomized trial
of an educational intervention to improve antibiotic



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































708 C. J. Crnich et al.
prescribing for pneumonia in New York nursing homes
demonstrated a significant improvement in adherence to
prescribing guidelines (from 50 to 82 %) in facilities where
education was targeted at both types of clinical staff [88].
In contrast, guideline adherence remained essentially
unchanged (69 versus 65 %) in nursing homes where
education was targeted solely at prescribing providers [88].
5.4 De-Escalation Interventions
Post-prescribing review and de-escalation interventions
(Q3–5 in Fig. 1) have had a profound impact on antibiotic
utilization in hospitals [106]. Not surprisingly, there is
evidence that de-escalation interventions have the potential
for similar impact in nursing homes. Fluoroquinolones are
among the most commonly prescribed antibiotics in US
nursing homes [14]; however, studies have shown that
providers rarely switch to agents with a more narrow
spectrum (e.g. trimethoprim–sulfamethoxazole) even when
culture results indicate a fully susceptible pathogen [23].
Moreover, a large observational study of nursing homes in
Ontario demonstrated that the majority of antibiotic pre-
scriptions exceeded durations of therapy sufficient for
treatment of the most commonly encountered infections
[17]. A follow-up study by these investigators confirmed
that only a minority of prescribers (22 %) employed short-
course therapy accepted in most guidelines [107]. Con-
vincing providers who typically prescribed antibiotics for
longer durations to prescribe antibiotics in a similar manner
would reduce the total number of antibiotic days in
Canadian nursing homes by 17 % [107]. A recently pub-
lished study of 100 prescribing events in a VA nursing
home demonstrated that 43 % of 1351 antibiotic days
associated with these events could have been safely elim-
inated either by stopping the antibiotic because it was
unnecessary or by shortening the duration of therapy [108].
Despite these opportunities, antibiotic de-escalation
interventions remain poorly studied in the nursing home
setting. A cluster-randomized study of a multi-component
intervention, which included a routine post-prescribing
review of empirically initiated antibiotics in 30 nursing
homes inLondon, demonstrated a 5 % reduction in antibiotic
consumption in intervention facilities comparedwith control
facilities despite low adherence to the post-review proce-
dures (26 %) [109]. Another study examined the impact of
an infectious disease consultative service, which involved
remote consultation services during daytime hours, aswell as
once-weekly in-person resident assessments, on antibiotic
prescribing and resident outcomes in a 160-bed VA nursing
home [110]. Significant declines in systemic antibiotic use
(-30 %;P\ 0.001) and facility rates ofC. difficile (slope-
0.03; P = 0.04) were observed over the 18-month inter-
vention period in this study.
6 Suggested Approach to Antibiotic Stewardship
in Nursing Homes
While there are many barriers to be overcome, the avail-
able data do suggest that antibiotic prescribing patterns in
nursing homes can be improved through interventions that
target different phases of the antibiotic prescribing process
(Fig. 1). Combining interventions that target the different
phases of the prescribing process and mitigate against
influences that promote inappropriate antibiotic prescribing
decisions (Fig. 2) has intrinsic appeal [85] but requires
more study [111]. These technical observations aside,
sustainability of any particular intervention is unlikely
unless nursing homes develop a dedicated focus on
improvement (Fig. 2—facility and staff factors) [112].
With this in mind, we propose that nursing homes first
develop structures and processes focused on understanding
local patterns, determinants and outcomes of antibiotic use
(Sects. 6.1–6.4), and then leverage this infrastructure to
develop staff/provider education (Sect. 6.5) and implement
targeted process interventions (Sect. 6.6).
6.1 Make Antibiotic Stewardship a Quality
Improvement Focus
Changing nursing home culture requires commitment at an
organizational level. Consequently, the first step is to
obtain buy-in from the facility leadership, including the
director of nursing and the medical director, to make
antibiotic stewardship a facility quality improvement focus.
Arguments that nursing home leaders find persuasive
include (1) a need to satisfy regulatory requirements
focused on appropriate use of medications; (2) federal
mandates to demonstrate meaningful organizational quality
assurance and performance improvement (QAPI) [113];
(3) emerging federal policies to promote and ultimately
require antibiotic stewardship activities across all health
care settings [6]; (4) organizational costs of treating
antibiotic-resistant infections and CDI [25, 114]; and
(5) how certain antibiotic stewardship interventions, par-
ticularly those focused around enhancing interdisciplinary
communication, can generate corollary benefits in other
nursing home processes and outcomes (e.g. enhanced
management of resident changes in condition).
6.2 Assemble a Team
Antibiotic prescribing in nursing homes is a complex
problem and involves a number of factors [115]. Facilities
dedicated to improving the quality of antibiotic prescribing
should assemble a multidisciplinary team that, at a mini-
mum, involves the facility medical director, the director of
nursing, an infection control practitioner and, if available,
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the facility pharmacist [116]. Initial meetings should focus
on identification of outcome measures that will be targeted
by improvement efforts, resources that will be needed to
achieve these objectives, and duties and responsibilities of
team members and expectations of nursing home staff and
prescribing providers as they relate to antibiotic use in the
facility. Seeking input from individuals with expertise in
antibiotic stewardship and infectious diseases in the region
can be particularly helpful at this stage. This team should
plan to meet at least monthly when first getting started.
6.3 Develop and Implement Basic Policies,
Guidelines and Goals
Provider orders for antibiotics should include clear docu-
mentation of the drug, dose, duration and indication. This
latter requirement is critical for tracking antibiotic utiliza-
tion (see below). Policies should be developed that dis-
courage the use of prophylactic antibiotics for prevention
of UTI and routine urine dipstick testing when evaluating a
resident experiencing a change in condition. The antibiotic
stewardship team should also consider developing policies
and guidelines that limit the use of fluoroquinolone
antibiotics, given their strong relationship to C. difficile
[117] and high rates of resistance among urinary pathogens
in many facilities [91, 118, 119]. More detailed guidelines
that specify the choice and duration of antibiotic therapy
for commonly encountered syndromes can be very effec-
tive in improving prescribing quality [81] but may require
substantial effort to develop.
6.4 Measure and Report Outcomes and Key Process
Indicators
A capability to measure and track process and outcomes is
a fundamental characteristic of successful quality
improvement [120]. Most nursing homes routinely track
commonly encountered infections [52, 121]. Adapting this
process to monitor, at a minimum, UTI events and CDI
should not prove too difficult for most facilities. We rec-
ommend that UTI be tracked in two ways: (1) treated UTI
events (i.e. all antibiotic starts regardless of whether the
event was a true infection); and (2) surveillance-defined
UTI events (i.e. only those events that satisfy published
criteria) [121, 122]. These measures can then be tracked in
a number of ways. Point prevalence measurements (e.g.
measuring the numbers of UTI events in the months before
and after an intervention) are relatively easy to perform.
Tracking outcomes using rates (e.g. UTI events per month/
resident-days per month 9 1000) is a more rigorous
approach, which may allow a facility to more accurately
assess the impact of multiple interventions over time. CDI
can be tracked in a similar manner using the National
Healthcare Surveillance Network (NHSN) criteria, which
consider the rate of non-duplicative positive tests per
10,000 resident-days [123]. Nursing homes may also con-
sider including residents transferred to their facility with
C. difficile in that rate [124]. Extending monitoring to other
types of infections, including those involving the respira-
tory tract and soft tissues, should be considered, as these
are the second and third most common indications for
initiation of antibiotic therapy in the nursing home setting
[14, 125]. Finally, facilities should discuss developing a
facility-specific antibiogram [119] in consultation with
their contract laboratory. The antibiogram is a tool that
facilities can use to identify common resistance patterns
(e.g. high levels of fluoroquinolone resistance), which may
influence providers’ empirical antibiotic decisions [91].
The small number of cultures collected in nursing homes
may create instability in observed patterns of resistance and
should be interpreted in consultation with individuals with
infectious disease expertise.
Nursing homes embarking on quality improvement in
antibiotic prescribing should seek to track antibiotic use in
some manner. Logistics, as well as the types of improve-
ment interventions that will be pursued, should guide the
measure(s) selected. Most nursing homes employ tracking
methods to identify residents experiencing a change in
condition, including those residents who are currently
receiving antibiotics [126]. Consequently, information on
antibiotic starts is readily available and can be tracked at
predefined time periods by the individual responsible for
infection surveillance in the facility. Cross-sectional
assessments of antibiotic use involve counting the number
of resident on antibiotics during a given day or week.
These assessments are fairly simple and do not require a
huge amount of effort, but they may not be as sensitive to
change as measures that are tracked more regularly.
Tracking antibiotic starts per month (like other continu-
ously monitored outcomes, this measure should be con-
verted to a rate using resident-days as a denominator) is a
more involved process, which allows facilities to trend and
visualize their data. These data can be further stratified by
indication (antibiotic starts for UTI, respiratory tract
infection, skin and soft tissue infection), particularly if the
indications for the antibiotic are routinely included on
prescriber orders (see above). Antibiotic start data are ideal
for tracking the effects of interventions focused on reduc-
ing unnecessary antibiotic use (e.g. reducing urine cultures)
but may not be very informative for interventions that
focus on reducing the duration of antibiotic therapy (e.g.
guidelines or de-escalation). Facilities seeking to imple-
ment interventions along these lines should seek to track
antibiotic utilization using either a days of therapy (DOT)
measure [127] or a defined daily dose (DDD) measure [16].
The DOT utilization measure is derived by adding up every
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day on which a resident receives a unique antibiotic. By
this method, receipt of multiple antibiotics has additive
effects on the measure (e.g. a resident who receives 5 days
of ceftriaxone and 5 days of azithromycin would generate
10 DOT even if both antibiotics are administered on the
same day). In contrast, the DDD utilization measure is
based on overall consumption of a particular antibiotic
adjusted for typical daily dosing in an adult patient with
intact renal function. By this approach, the total number of
grams of each antibiotic used (or purchased) are summed
over the period of interest and divided by the World Health
Organization’s assigned DDD value [128]. Manual col-
lection of these types of data poses a challenge. Conse-
quently, working with the facility pharmacist to automate
this process through queries of the pharmacy information
system is recommended.
6.5 Education
Education is a foundational activity of any ASP and can be
used to target all three domains influencing prescribing
decisions in nursing homes (Fig. 2—patient and family
factors, facility and staff factors, health care provider fac-
tors). Educational content should cover the importance of
stewardship, plans for implementation of specific stew-
ardship activities and the responsibilities of clinical staff in
achieving stewardship goals. Education should be targeted
and tailored to nursing assistants, nursing staff, providers,
residents and families. While not focused on antibiotic
prescribing practices, a recently published study performed
in 12 Michigan nursing homes demonstrated that a multi-
modal educational intervention focused on common
infection prevention practices and care processes associ-
ated with indwelling urinary catheters and feeding tubes
was associated with significant reductions in rates of
MRSA acquisition [absolute risk reduction (ARR) 0.78;
95 % CI 0.65–0.95] and catheter-associated UTI
(ARR 0.69; 95 % CI 0.49–0.99) [129]. Resident and fam-
ily education, when combined with staff and provider
education, as well as interventions to enhance interdisci-
plinary communication, has also recently been shown to be
associated with reductions in antibiotic use in nursing
homes [85]. Studies such as these demonstrate that edu-
cational interventions can be powerful tools for changing
behaviours but likely need to target multiple individuals
[88] and be delivered via a number of modalities—in-
cluding in-service training sessions, newsletters, pocket
guides, posters and brochures—in order to be maximally
effective.
6.6 Next Steps
Once a facility has established its basic policies, outcome
and process measures and has developed basic educational
activities, the stewardship team should use the collected
data to set new goals and select more active strategies in
order to achieve these goals. As noted above, antibiotic
decision-making in nursing homes is heavily influenced by
Fig. 3 Decision pathway to reduce unnecessary diagnostic testing of urine samples in long-term care facilities (adapted from Crnich and
Drinka [94]). CVAT costovertebral angle tenderness, UA urinalysis, UCx urine culture, UTI urinary tract infection
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diagnostic test results, and we believe that facilities will see
the biggest return on investment through a focus on
implementing interventions to reduce orders for urine
cultures. Urine dipstick and urinalysis tests, despite being
reliable methods for ruling out bacteriuria [130, 131], are
often used to justify orders for urine cultures. Mild
abnormalities on urinalysis, such as positive nitrite or
leukocyte esterase readings on dipsticks, or moderate
numbers of white blood cells on microscopy, are common
in asymptomatic bacteriuria [96, 97], so neither test should
be used as a screen for UTI. Consequently, nursing homes
should instead develop and use protocols that restrict all
urine testing to residents with a high probability of having a
UTI (Fig. 3). These protocols should be operationalized not
only through education of providers but, given their influ-
ence on provider decision-making [42, 43], also through
engagement of nursing staff, who should be empowered to
discourage providers from ordering diagnostic urine tests in
the absence of specific evidence-based criteria. Tracking
the frequency of urine cultures and the number of treated
UTI events that do not satisfy surveillance definitions [121]
provides targets that a facility can follow in order to assess
the impact of the intervention. Other approaches based on
improving interdisciplinary communication through tools
that standardize documentation and sharing of important
patient information, as well as development of a process to
ensure consistent post-prescribing review and de-escala-
tion, may represent a greater challenge but are worth
considering, particularly if success in reducing the fre-
quency of urine cultures has been achieved.
7 Unanswered Questions and Future Directions
The emerging crisis in antibiotic resistance will require a
concerted effort to improve antibiotic stewardship across
all health care settings [6]. Considerable progress has been
made in our understanding of the extent and determinants
of inappropriate antibiotic use in nursing homes. While
there is accumulating evidence that interventions focused
on processes (e.g. urine testing) associated with the initial
antibiotic decision can reduce unnecessary antibiotic use,
there remains a critical need to identify interventions that
target post-prescribing decision-making (e.g. review and
de-escalation). There is also a need for more research on
how to implement both types of stewardship interventions
with fidelity and sustain them over time, particularly in
nursing homes with limited quality improvement resources.
Finally, there is a need for studies that evaluate the effects
of stewardship interventions on facility and resident out-
comes, including health care costs, as well as rates of
infections caused by C. difficile and multidrug-resistant
bacteria.
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